Underweight KO: Trim 15-20% on rallies into $87.50-87.66, preserve defensive ballast and 2.48% dividend
Underweight rating reflects convergent concerns: 24.5x forward P/E at 85th-percentile historical band with 3.89 PEG against ~4% growth, broken short-term technical momentum (50 SMA break, negative MACD, RSI at 44.86), FCF coverage concerns (0.58x TTM FCF), and slow-bleed alpha decay validated across five Hold iterations. However, Underweight—not SELL—because: 9/17 Underweight failure (+0.3% alpha when trim thesis required downside) is binding empirical constraint; quality floor is real (42% ROE, 64-year dividend streak, AAA credit, 0.34 beta, $15.8B liquidity); net income dividend coverage at 1.6x ($13B+ annual income vs. $9B dividend) is structurally sound; macro tailwind for defensives remains intact (92% no-recession odds); lower Bollinger band at $85.67 successfully defended intraday. The 15-20% trim is the Goldilocks response: acknowledges multiple compression risk, respects 9/17 empirical constraint, preserves defensive ballast and 2.48% dividend, maintains tactical optionality for re-entry at $78-80 or post-Q3 earnings.
| Position | Action |
|---|---|
| Position currently overweight relative to risk/return | Trim 15-20% total exposure (not 25-40% aggressive trim or 10-15% insufficient trim) |
| First tranche execution | Trim ~10% on relief bounce into $87.00-87.50 zone; sell resistance rejections at 10 EMA or VWMA, not at $86.50 with no momentum |
| Second tranche execution | Trim additional 5-10% ONLY on volume-confirmed push above $87.66 (50 SMA reclaim) with RSI>50 AND MACD turning positive; failed reclaim test (close below within 2 sessions) means NO second tranche |
| KO rallies above $92 (prior August high) on strong volume | Reconsider Underweight rating; breakout invalidates technical caution |
| KO closes below $84 | Accelerate trimming toward 30-40% total exposure, confirming distribution |
| KO closes below $83.50 on volume | Exit additional position (binding stop) |
| KO weekly close at $78.40 (200 SMA) | Hard invalidation; full re-evaluation toward SELL |
KO's Q2 2026 acceleration in revenue, margins, and free cash flow—combined with a technically intact long-term uptrend and a macro backdrop of soft-landing probabilities at multi-month highs—makes the 5.4% pullback from $91.94 to $86.51 a compelling accumulation opportunity in a high-quality, dividend-growing franchise.
| Indicator | Value | Signal |
|---|---|---|
| close_50_sma | $87.66 | bearish |
| close_200_sma | $79.21 | bullish |
| close_10_ema | $86.82 | bearish |
| macd | -0.35 | bearish |
| macd_signal | -0.07 | bearish |
| rsi | 44.86 | neutral |
| boll_middle | $87.49 | bearish |
| boll_upper | $89.31 | neutral |
| boll_lower | $85.67 | neutral |
| atr | 1.23 | neutral |
| vwma | $87.33 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Relief bounce into $87.00-87.50 zone; rejection at 10 EMA or VWAP confirms resistance
Then: Trim ~10% at $86-87
KO's pricing power and operational efficiency are driving structural margin expansion, not cyclical improvement
EV: +4% to +5% from current levels to first technical resistance ($87.49-$87.66), with tight ~$1.20 risk to the lower Bollinger Band · concedes: The historical revenue CAGR of 3.7% is below-market; KO is a slow-but-steady compounder rather than a high-growth name; FX has been a structural drag on reported results; Premium valuation at 26x P/E leaves little room for error; GLP-1 volume risk, while overstated by bears, remains a long-term secular concern for full-sugar soda exposure
KO is fundamentally a ~3-4% revenue grower currently priced like a 10%+ compounder at 24.53x forward P/E, with a PEG ratio of 3.89; the bear case requires only multiple mean-reversion while the bull case demands multiple expansion, FCF coverage, volume stabilization, and GLP-1 non-impact—all simultaneously.
EV: -8.1% (base case -9.8%, bear case -19.1%, bull case +6.3%; real expected total return: -5.5% over 12 months) · concedes: KO is a wonderful business with strong brand equity and 2.48% dividend yield; Q2 2026 was an actual beat with 6.7% revenue growth and all-time high margins; The 200 SMA at $79.21 represents reasonable long-term support; The 92% no-recession probability reduces tail-risk scenario probability; Monster equity income provides some passive exposure to energy drink growth
→ vs conservative: 200 SMA at $79.21 is a lagging indicator that tells you what happened, not what will happen; 'wait for reclaim' at $87.66 means selling at a worse level, not risk management
→ vs conservative: 2.48% yield inferior to 4%+ Treasuries with zero equity risk; 'HOLD and collect' ignores opportunity cost and capital preservation optionality
→ vs neutral: Macro tailwinds don't prevent multiple compression at individual stock level; 24.5x forward earnings with 3.89 PEG ratio already priced in soft-landing optimism
→ vs neutral: 'Underlying net income conversion remains robust' and 'stabilizing toward $7-8B normalized run-rate' is insufficient; 0.58x FCF coverage is not a dividend aristocrat, it's a dividend at risk
→ vs conservative: HOLD recommendation leaves capital exposed to asymmetric downside; both analysts doing nothing while technicals deteriorate and valuation sits at multi-year highs
| close | $86.51 | neutral |
| 2026_high | $91.94 | neutral |
| dividend_quarterly | $0.53 | bullish |
Support: 85.67 · 79.21 · 82 | Resistance: 87.66 · 87.49 · 87.33 · 89.31 · 91.94
KO is in a mild short-term pullback within an intact long-term uptrend. The 50 SMA at $87.66 has been broken to the downside (bearish tactical signal), while the 200 SMA at $79.21 remains well below price confirming the secular uptrend. RSI at 44.86 is neutral-leaning-weak, MACD is negative at -0.35 below signal at -0.07, and price is below the 10 EMA at $86.82 and VWMA at $87.33. The Bollinger lower band at $85.67 is the critical support level that must hold to confirm a healthy pullback rather than a deeper correction. The recommendation is HOLD while waiting for price to reclaim the 50 SMA at $87.66 before initiating new long exposure.
Market Cap
$372.21 B
Enterprise Value
~$405.8 B
Beta
0.318
52-Week Range
$65.84 – $92.49
50-Day MA
$87.94
200-Day MA
$80.01
TTM EPS
$3.33
Forward EPS
$3.53
TTM Revenue
$50.13 B
TTM Net Income
$14.32 B
Dividend Yield
2.48%
Book Value/Share
$8.40
ROE
42.05%
ROA
9.40%
Revenue CAGR 2022–2025
~3.7%
Net Income Growth 2024→2025
+23.3%
2022 Revenue
$43.00 B
2022 Gross Profit
$25.00 B
2022 Gross Margin
58.1%
2022 Operating Income
$12.04 B
2022 Operating Margin
28.0%
2022 Net Income
$9.54 B
2022 Diluted EPS
$2.19
2022 EBITDA
$13.83 B
2023 Revenue
$45.75 B
2023 Gross Profit
$27.23 B
2023 Gross Margin
59.5%
2023 Operating Income
$13.10 B
2023 Operating Margin
28.6%
2023 Net Income
$10.71 B
2023 Diluted EPS
$2.47
2023 EBITDA
$15.61 B
2024 Revenue
$47.06 B
2024 Gross Profit
$28.74 B
2024 Gross Margin
61.1%
2024 Operating Income
$14.02 B
2024 Operating Margin
29.8%
2024 Net Income
$10.63 B
2024 Diluted EPS
$2.46
2024 EBITDA
$15.82 B
2025 Revenue
$47.94 B
2025 Gross Profit
$29.54 B
2025 Gross Margin
61.6%
2025 Operating Income
$14.91 B
2025 Operating Margin
31.1%
2025 Net Income
$13.11 B
2025 Diluted EPS
$3.04
2025 EBITDA
$18.70 B
TTM Profit Margin
28.6%
TTM Operating Margin
34.9%
TTM Gross Margin
61.9%
Q2 2025 Revenue
$12.54 B
Q2 2025 Gross Margin
62.4%
Q2 2025 Op. Income
$4.35 B
Q2 2025 Net Income
$3.81 B
Q2 2025 Diluted EPS
$0.88
Q3 2025 Revenue
$12.46 B
Q3 2025 Gross Margin
61.5%
Q3 2025 Op. Income
$4.01 B
Q3 2025 Net Income
$3.70 B
Q3 2025 Diluted EPS
$0.86
Q4 2025 Revenue
$11.82 B
Q4 2025 Gross Margin
60.0%
Q4 2025 Op. Income
$2.86 B
Q4 2025 Net Income
$2.27 B
Q4 2025 Diluted EPS
$0.53
Q1 2026 Revenue
$12.47 B
Q1 2026 Gross Margin
63.0%
Q1 2026 Op. Income
$4.37 B
Q1 2026 Net Income
$3.92 B
Q1 2026 Diluted EPS
$0.91
Q2 2026 Revenue
$13.38 B
Q2 2026 Gross Margin
62.9%
Q2 2026 Op. Income
$4.70 B
Q2 2026 Net Income
$4.43 B
Q2 2026 Diluted EPS
$1.03
Q2 2026 Operating Margin
35.1%
Q2 2026 FCF
$5.10 B
Q2 2026 Net Debt Reduction
$2.68 B
Cost of Revenue Q2 2026
$4.97 B
SG&A Q2 2026
$3.72 B
Effective Tax Rate Q2 2026
18.9%
Equity-Method Income
$0.6 B/quarter
2022 Total Assets
$92.76 B
2022 Total Liabilities
$66.94 B
2022 Stockholders' Equity
$24.11 B
2022 Total Debt
$39.15 B
2022 Net Debt
$29.63 B
2022 Cash & ST Inv.
$11.63 B
2022 Working Capital
$2.87 B
2022 Goodwill & Intangibles
$33.63 B
2023 Total Assets
$97.70 B
2023 Total Liabilities
$70.22 B
2023 Stockholders' Equity
$25.94 B
2023 Total Debt
$42.06 B
2023 Net Debt
$32.70 B
2023 Cash & ST Inv.
$13.66 B
2023 Working Capital
$3.16 B
2023 Goodwill & Intangibles
$32.71 B
2024 Total Assets
$100.55 B
2024 Total Liabilities
$74.18 B
2024 Stockholders' Equity
$24.86 B
2024 Total Debt
$44.52 B
2024 Net Debt
$33.69 B
2024 Cash & ST Inv.
$14.57 B
2024 Working Capital
$0.75 B
2024 Goodwill & Intangibles
$31.44 B
2025 Total Assets
$104.82 B
2025 Total Liabilities
$70.54 B
2025 Stockholders' Equity
$32.17 B
2025 Total Debt
$45.49 B
2025 Net Debt
$35.22 B
2025 Cash & ST Inv.
$15.81 B
2025 Working Capital
$9.76 B
2025 Goodwill & Intangibles
$28.02 B
Q2 2026 Total Assets
$107.92 B
Q2 2026 Total Liabilities
$69.61 B
Q2 2026 Stockholders' Equity
$36.15 B
Q2 2026 Total Debt
$43.54 B
Q2 2026 Net Debt
$30.64 B
Q2 2026 Cash & ST Inv.
$16.37 B
Q2 2026 Working Capital
$7.68 B
Q2 2026 Goodwill & Intangibles
$27.96 B
Debt/Equity
1.16
Current Ratio
1.31
Tangible Book Value 2025
$4.1 B
Tangible Book Value Q2 2026
$8.2 B
Goodwill Q2 2026
$15.46 B
Annual Capex
~$2.1 B
2022 Operating Cash Flow
$11.02 B
2022 Capex
($1.48) B
2022 Free Cash Flow
$9.53 B
2022 Dividends Paid
($7.62) B
2022 Net Buybacks
($1.42) B
2022 Net Debt Issuance
($0.96) B
2023 Operating Cash Flow
$11.60 B
2023 Capex
($1.85) B
2023 Free Cash Flow
$9.75 B
2023 Dividends Paid
($7.95) B
2023 Net Buybacks
($2.29) B
2023 Net Debt Issuance
$1.86 B
2024 Operating Cash Flow
$6.81 B
2024 Capex
($2.06) B
2024 Free Cash Flow
$4.74 B
2024 Dividends Paid
($8.36) B
2024 Net Buybacks
($1.80) B
2024 Net Debt Issuance
$2.53 B
2025 Operating Cash Flow
$7.41 B
2025 Capex
($2.11) B
2025 Free Cash Flow
$5.30 B
2025 Dividends Paid
($8.78) B
2025 Net Buybacks
($0.75) B
2025 Net Debt Issuance
$0.01 B
TTM FCF
$5.22 B
Net Income to OCF Conversion TTM
~72%
P/E TTM
25.98
Forward P/E
24.53
PEG Ratio
3.89
P/B
10.30
EV/EBITDA TTM
~23.9x
FCF Yield TTM
~1.4%
Payout Ratio TTM
~63%
Q2 2026 Dividend Paid
$2.281 B
Trailing 4Q Dividends
~$9.06 B
Annualized Dividend/Share
~$2.10
FY 2025 Share Repurchases
$746 M
Diluted Shares Outstanding
4.303 B
Cumulative FX Translation Drag
~$12.7 B
Q4 2025 Impairment Charge
$1.05 B
Q4 2025 Unusual Items
$1.98 B
Working Capital Swing 2025
$7.17 B unfavorable
Dividend Growth Streak
64+ years
Strengths
Concerns
Coca-Cola Company (KO) demonstrates strong fundamental quality with accelerating Q2 2026 momentum — revenue +6.7% YoY, operating margin at all-time high of 35.1%, and EPS of $1.03 (+17% YoY). The company has expanded gross margins from 58.1% (2022) to 61.6% (2025) through pricing power and asset-light refranchising, while maintaining exceptional ROE of 42.05% and paying a sustainable ~63% payout ratio. However, the stock trades at a premium 26x P/E with only ~6% expected growth, limiting upside unless growth re-rates higher; the HOLD rating reflects balanced risk/reward. Key catalysts for upgrade include sustained 5%+ revenue growth confirming volume re-acceleration or a 5–10% pullback toward the 200-day MA of $80.01. KO remains a premier defensive holding with 64+ years of dividend growth, a 2.48% yield, and active deleveraging that cut net debt by $9 billion from peak Q2 2025.
Macro: Soft-landing / no-recession regime priced by prediction markets: 96% probability of no Fed rate cuts in 2026 (stable rate environment), 92% probability of no US recession in 2026, 8% probability of inflation breaching 5%, 87% probability inflation stays below 4.5%. Deflationary pressures winning, growth holding up, Fed on hold. Nasdaq at fresh highs, Dow slipping, small caps range-bound. Barron's explicitly questioning Wall Street consensus to sell consumer staples.